Get the Stockscreener App
0.00
100.00%
-3.07
Mei Pharma Inc stock is traded at $0.00, with a volume of 0.
It is down -100.00% in the last 24 hours and down -100.00% over the past month.
MEI Pharma Inc is focused on the clinical development of novel therapies for cancer. The company's clinical drug candidate includes Pracinostat, an orally available histone deacetylase inhibitor for the treatment of patients with acute myeloid leukemia and myelodysplastic syndrome. Its clinical development portfolio also includes Zandelisib, an oral inhibitor of phosphatidylinositide 3-kinase delta for the treatment of patients with recurrent chronic lymphocytic leukemia or follicular non-Hodgkin's lymphoma; and ME-344, an isoflavone-based mitochondrial inhibitor for the treatment of HER2-negative breast cancer and Pracinostat, an oral histone deacetylase inhibitor. Geographically, all the business activities function through the region of the United States.
See More
Previous Close:
$3.07
Open:
$0
24h Volume:
0
Relative Volume:
0.00
Market Cap:
$100.81M
Revenue:
$105.38M
Net Income/Loss:
$17.78M
P/E Ratio:
0.00
EPS:
2.67
Net Cash Flow:
$-50.48M
1W Performance:
-100.00%
1M Performance:
-100.00%
6M Performance:
-100.00%
1Y Performance:
-100.00%
1-Day Range:
$0.00
$0.00
1-Week Range:
$0.00
$0.00
52-Week Range:
$0.00
$9.00
Mei Pharma Inc Stock (MEIP) Company Profile
Name
Mei Pharma Inc
Sector
Industry
Phone
858-369-7100
Address
11455 EL CAMINO REAL, SAN DIEGO, CA
Compare MEIP with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
MEIP
Mei Pharma Inc
|
0.00 | 100.81M | 105.38M | 17.78M | -50.48M | 2.67 |
|
VRTX
Vertex Pharmaceuticals Inc
|
452.04 | 113.14B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
741.29 | 78.49B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ARGX
Argen X Se Adr
|
877.94 | 54.76B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
397.55 | 54.51B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
INSM
Insmed Inc
|
197.01 | 41.64B | 447.02M | -1.18B | -906.14M | -6.1812 |
Mei Pharma Inc Stock (MEIP) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jul-23-24 | Downgrade | Laidlaw | Buy → Hold |
| Mar-25-22 | Downgrade | Jefferies | Buy → Hold |
| Mar-25-22 | Downgrade | Stifel | Buy → Hold |
| Mar-25-22 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| Feb-03-22 | Initiated | Jefferies | Buy |
| Sep-22-20 | Initiated | Alliance Global Partners | Buy |
| May-29-20 | Initiated | SunTrust | Buy |
| Dec-20-18 | Initiated | H.C. Wainwright | Buy |
| Jul-27-18 | Upgrade | Stifel | Hold → Buy |
| Jul-13-18 | Initiated | SunTrust | Buy |
| Apr-18-16 | Reiterated | Wedbush | Neutral |
| Mar-23-15 | Downgrade | ROTH Capital | Buy → Neutral |
| Dec-18-14 | Reiterated | ROTH Capital | Buy |
| Oct-16-14 | Reiterated | ROTH Capital | Buy |
| Jul-08-14 | Resumed | Brean Capital | Buy |
| Oct-22-13 | Reiterated | Stifel | Buy |
| Apr-15-13 | Initiated | Stifel | Buy |
View All
Mei Pharma Inc Stock (MEIP) Latest News
What analysts say about MEI Pharma Inc MMI0 stockTrend Following Strategies & Analysts Are Raving About These Shares - earlytimes.in
Will MEI Pharma Inc. (MMI0) stock rise with strong economyWeekly Trade Review & Capital Efficiency Focused Strategies - Newser
How MEI Pharma Inc. stock reacts to Fed rate cutsWeekly Profit Report & Free Weekly Chart Analysis and Trade Guides - Newser
Is MEI Pharma Inc. (MMI0) stock included in top ETFsRate Cut & Real-Time Volume Trigger Notifications - Newser
Will MEI Pharma Inc. stock see PE expansionJuly 2025 Patterns & AI Enhanced Market Trend Forecasts - BỘ NỘI VỤ
Published on: 2025-11-29 05:00:13 - earlytimes.in
Can Shanti Spintex Limited Withstand a Global Recession Risk Profile AnalyzedStop Loss Placement Tips & Build Wealth With Zero-Cost Tools - earlytimes.in
Is MEI Pharma Inc. (MMI0) stock attractive post correctionJuly 2025 Summary & Low Risk High Reward Ideas - newser.com
Why MEI Pharma Inc. stock is in analyst buy zoneTrade Volume Report & Capital Efficiency Focused Strategies - newser.com
MEI Pharma Inc options imply 12.8% move in share price post-earnings - MSN
How MEI Pharma Inc. (MMI0) stock reacts to stronger dollarExit Point & Weekly Watchlist of Top Performers - newser.com
Can MEI Pharma Inc. (MMI0) stock surprise markets with earningsStock Surge & Expert Curated Trade Setups - newser.com
Is MEI Pharma Inc. (MMI0) stock a momentum leaderJuly 2025 Institutional & Scalable Portfolio Growth Methods - newser.com
Can MEI Pharma Inc. (MMI0) stock sustain margin levelsWeekly Investment Report & Free Low Drawdown Momentum Trade Ideas - newser.com
How MEI Pharma Inc. stock benefits from strong dollarFed Meeting & Real-Time Sentiment Analysis - newser.com
Why institutional investors increase stakes in MEI Pharma Inc. (MMI0) stock2025 Trading Volume Trends & AI Driven Stock Price Forecasts - newser.com
Why MEI Pharma Inc. (MMI0) stock is favored by hedge fundsVolume Spike & Real-Time Volume Analysis Alerts - newser.com
Can MEI Pharma Inc. stock deliver surprise earnings beatBear Alert & Risk Managed Investment Strategies - newser.com
How to use a screener to detect MEI Pharma Inc. breakoutsTreasury Yields & Long-Term Growth Plans - newser.com
Risk adjusted return profile for MEI Pharma Inc. analyzedTrade Signal Summary & Free Safe Capital Growth Stock Tips - newser.com
Using R and stats models for MEI Pharma Inc. forecastingGold Moves & Free Safe Capital Growth Stock Tips - newser.com
MEI Pharma Inc. stock prediction for this week2025 Price Momentum & Scalable Portfolio Growth Ideas - newser.com
Will MEI Pharma Inc. continue its uptrendQuarterly Portfolio Report & Low Volatility Stock Recommendations - newser.com
Can volume confirm reversal in MEI Pharma Inc.Quarterly Profit Report & Long-Term Investment Growth Plans - newser.com
Mei Pharma Inc Stock (MEIP) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.08%
0.91%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):